Page last updated: 2024-08-22

butoxamine and Innate Inflammatory Response

butoxamine has been researched along with Innate Inflammatory Response in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, X; Dong, H; Han, H; Hou, L; Pei, Y; Xiong, L; Zhang, Z1

Other Studies

1 other study(ies) available for butoxamine and Innate Inflammatory Response

ArticleYear
β2-adrenergic receptor antagonist butoxamine partly abolishes the protection of 100% oxygen treatment against zymosan-induced generalized inflammation in mice.
    Shock (Augusta, Ga.), 2011, Volume: 36, Issue:3

    Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Antagonists; Animals; Butoxamine; Cyclic AMP; Inflammation; Mice; Oxygen; Reactive Oxygen Species; Receptors, Adrenergic, beta-2; Zymosan

2011